Onconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intravenous Rigosertib in Higher-Risk Myelodysplastic Syndromes in Brazil

NEXT STORY
RedHill Biopharma Initiates U.S. Promotion of Aemcolo® for Travelers’ Diarrhea
PREV STORY
ADMA Biologics Added to NASDAQ Biotechnology Index
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Health PEI Becomes First Government Agency to Bring Rendever’s Shared Virtual Reality Platform to Hospitals and Long Term Care Homes

author_avatar
NASDAQ Market News

Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Published in American Journal of Respiratory and Critical Care Medicine

--As previously reported, study met primary endpoint of culture conversion (p<0.0001)-- --ALIS under FDA ...

author_avatar
NASDAQ Market News

Reunion Rehabilitation Hospital Denver Announces Grand Opening

author_avatar
NASDAQ Market News